Cargando…

Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019

Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term...

Descripción completa

Detalles Bibliográficos
Autores principales: Ali, Kameran M., Ali, Ayad M., Tawfeeq, Hassan M., Figueredo, Grazziela P., Rostam, Hassan M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250600/
https://www.ncbi.nlm.nih.gov/pubmed/33830538
http://dx.doi.org/10.1002/jmv.27002
_version_ 1783717060591747072
author Ali, Kameran M.
Ali, Ayad M.
Tawfeeq, Hassan M.
Figueredo, Grazziela P.
Rostam, Hassan M.
author_facet Ali, Kameran M.
Ali, Ayad M.
Tawfeeq, Hassan M.
Figueredo, Grazziela P.
Rostam, Hassan M.
author_sort Ali, Kameran M.
collection PubMed
description Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term. Here, we examined erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum albumin biomarkers in patients with a history of severe and mild‐to‐moderate COVID‐19 following their recovery. In patients with severe COVID‐19 serum albumin had a strong negative correlation with both ESR and CRP levels (R (2) = − 0.861 and R (2) = − 0.711), respectively. Also, there was a positive correlation between ESR and CRP level (R (2) = 0.85) in the same group. However, there was no correlation between these biomarkers among mild‐to‐moderate COVID‐19 patients. In addition, no correlation was recorded between the severe and mild‐to‐moderate COVID‐19 groups. This finding highlights the sustained elevation of ESR and CRP level and reduced serum albumin level that may persist postrecovery in patients with a history of severe COVID‐19.
format Online
Article
Text
id pubmed-8250600
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-82506002021-07-02 Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019 Ali, Kameran M. Ali, Ayad M. Tawfeeq, Hassan M. Figueredo, Grazziela P. Rostam, Hassan M. J Med Virol Research Articles Coronavirus disease 2019 (COVID‐19) is caused by a contagious virus that has spread to more than 200 countries, territories, and regions. Thousands of studies to date have examined all aspects of this disease, yet little is known about the postrecovery status of patients, especially in the long term. Here, we examined erythrocyte sedimentation rate (ESR), C‐reactive protein (CRP), and serum albumin biomarkers in patients with a history of severe and mild‐to‐moderate COVID‐19 following their recovery. In patients with severe COVID‐19 serum albumin had a strong negative correlation with both ESR and CRP levels (R (2) = − 0.861 and R (2) = − 0.711), respectively. Also, there was a positive correlation between ESR and CRP level (R (2) = 0.85) in the same group. However, there was no correlation between these biomarkers among mild‐to‐moderate COVID‐19 patients. In addition, no correlation was recorded between the severe and mild‐to‐moderate COVID‐19 groups. This finding highlights the sustained elevation of ESR and CRP level and reduced serum albumin level that may persist postrecovery in patients with a history of severe COVID‐19. John Wiley and Sons Inc. 2021-05-03 2021-07 /pmc/articles/PMC8250600/ /pubmed/33830538 http://dx.doi.org/10.1002/jmv.27002 Text en © 2021 The Authors. Journal of Medical Virology Published by Wiley Periodicals LLC https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Articles
Ali, Kameran M.
Ali, Ayad M.
Tawfeeq, Hassan M.
Figueredo, Grazziela P.
Rostam, Hassan M.
Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title_full Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title_fullStr Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title_full_unstemmed Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title_short Hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
title_sort hypoalbuminemia in patients following their recovery from severe coronavirus disease 2019
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8250600/
https://www.ncbi.nlm.nih.gov/pubmed/33830538
http://dx.doi.org/10.1002/jmv.27002
work_keys_str_mv AT alikameranm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019
AT aliayadm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019
AT tawfeeqhassanm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019
AT figueredograzzielap hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019
AT rostamhassanm hypoalbuminemiainpatientsfollowingtheirrecoveryfromseverecoronavirusdisease2019